A detailed history of David Katz (Matrix Asset Advisors Inc) transactions in Abb Vie Inc. stock. As of the latest transaction made, Matrix Asset Advisors Inc holds 142,956 shares of ABBV stock, worth $23.8 Million. This represents 3.12% of its overall portfolio holdings.

Number of Shares
142,956
Previous 164,427 13.06%
Holding current value
$23.8 Million
Previous $25.5 Million 2.16%
% of portfolio
3.12%
Previous 3.25%

Shares

38 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$159.82 - $182.1 $3.43 Million - $3.91 Million
-21,471 Reduced 13.06%
142,956 $26 Million
Q4 2023

Jan 24, 2024

BUY
$137.6 - $154.97 $430,000 - $484,281
3,125 Added 1.94%
164,427 $25.5 Million
Q3 2023

Oct 12, 2023

BUY
$133.59 - $154.65 $42,748 - $49,488
320 Added 0.2%
161,302 $24 Million
Q2 2023

Jul 18, 2023

BUY
$132.51 - $164.9 $393,819 - $490,082
2,972 Added 1.88%
160,982 $21.7 Million
Q1 2023

Apr 13, 2023

SELL
$144.61 - $166.54 $64,929 - $74,776
-449 Reduced 0.28%
158,010 $25.2 Million
Q4 2022

Jan 19, 2023

SELL
$138.31 - $165.87 $587,125 - $704,118
-4,245 Reduced 2.61%
158,459 $0
Q3 2022

Oct 24, 2022

BUY
$134.21 - $153.93 $1.97 Million - $2.25 Million
14,646 Added 9.89%
162,704 $21.8 Million
Q2 2022

Jul 15, 2022

SELL
$137.62 - $174.96 $4.24 Million - $5.39 Million
-30,824 Reduced 17.23%
148,058 $22.7 Million
Q1 2022

Apr 22, 2022

SELL
$131.98 - $163.75 $7.18 Million - $8.9 Million
-54,381 Reduced 23.31%
178,882 $29 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $16,759 - $21,205
156 Added 0.07%
233,263 $31.6 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $194,180 - $220,423
1,825 Added 0.79%
233,107 $25.1 Million
Q2 2021

Aug 16, 2021

BUY
$105.21 - $117.21 $2,314 - $2,578
22 Added 0.01%
231,282 $26.1 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $352,832 - $388,426
3,449 Added 1.51%
231,260 $25 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $353,029 - $476,626
4,386 Added 1.96%
227,811 $24.4 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $3.29 Million - $3.86 Million
-38,261 Reduced 14.62%
223,425 $19.6 Million
Q2 2020

Aug 13, 2020

SELL
$73.37 - $98.18 $521,073 - $697,274
-7,102 Reduced 2.64%
261,686 $25.7 Million
Q1 2020

May 11, 2020

SELL
$64.5 - $97.79 $18.3 Million - $27.7 Million
-283,110 Closed
0 $0
Q4 2019

Feb 11, 2020

SELL
$72.13 - $90.25 $67,802 - $84,835
-940 Reduced 0.33%
283,110 $25.1 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $3.03 Million - $3.64 Million
48,040 Added 20.36%
284,050 $21.5 Million
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $845,033 - $1.08 Million
-12,862 Reduced 5.17%
236,010 $17.2 Million
Q1 2019

May 10, 2019

BUY
$77.14 - $90.79 $96,116 - $113,124
1,246 Added 0.5%
248,872 $20.1 Million
Q4 2018

Feb 12, 2019

SELL
$77.85 - $96.01 $16,192 - $19,970
-208 Reduced 0.08%
247,626 $22.8 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $36,097 - $40,129
406 Added 0.16%
247,834 $23.4 Million
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $197,964 - $234,237
-2,205 Reduced 0.88%
247,428 $22.9 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $353,226 - $473,003
-3,839 Reduced 1.51%
249,633 $23.6 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $666,774 - $731,173
-7,445 Reduced 2.85%
253,472 $24.5 Million
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $60,350 - $77,086
-864 Reduced 0.33%
260,917 $23.2 Million
Q2 2017

Aug 09, 2017

SELL
N/A
-210 Reduced 0.08%
261,781 $19 Million
Q1 2017

May 10, 2017

SELL
N/A
-680 Reduced 0.26%
261,991 $17.1 Million
Q4 2016

Feb 08, 2017

BUY
N/A
90,091 Added 52.2%
262,671 $16.4 Million
Q3 2016

Nov 07, 2016

BUY
N/A
36,110 Added 26.46%
172,580 $10.9 Million
Q2 2016

Aug 03, 2016

BUY
N/A
59,269 Added 76.77%
136,470 $8.45 Million
Q1 2016

May 05, 2016

BUY
N/A
15,855 Added 25.85%
77,201 $4.41 Million
Q4 2015

Feb 08, 2016

BUY
N/A
61,346 New
61,346 $3.63 Million
Q3 2015

Nov 10, 2015

SELL
N/A
-3,234 Closed
0 $0
Q2 2015

Aug 07, 2015

BUY
N/A
3,234 New
3,234 $217,000
Q1 2015

May 08, 2015

SELL
N/A
-3,234 Closed
0 $0
Q4 2014

Feb 10, 2015

BUY
N/A
3,234
3,234 $212,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track David Katz's Portfolio

Track David Katz Portfolio

Follow David Katz (Matrix Asset Advisors Inc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Matrix Asset Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Matrix Asset Advisors Inc and David Katz with notifications on news.